SI
OREX

Standard Investments’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Standard Investments’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-27,119
Closed -$1.34M – 151
2015
Q2 		$1.34M Buy
27,119
+16,816
+163% +$1.01M 0.08% 84
2015
Q1 		$807K Buy
+10,303
New +$639K 0.05% 104
2014
Q2 		– Sell
-13,075
Closed -$850K – 242
2014
Q1 		$850K Buy
13,075
+3,390
+35% +$229K 0.08% 137
2013
Q4 		$545K Buy
+9,685
New +$544K 0.04% 129

Other funds holding OREX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Standard Investments's OREX Position: Q3 2015 in Review

Standard Investments sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2015, closing a stake of 27,119 shares — an estimated $1.34M sold.

Standard Investments first reported a position in OREX in Q4 2013 and held it in 4 quarters. The position peaked at $1.34M in Q2 2015. 132 funds tracked by Wall St. Rank hold OREX as of Q3 2015.

  • Standard Investments reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
  • Standard Investments sold 27,119 Orexigen Therapeutics, Inc. shares in Q3 2015, an estimated $1.34M.
  • Standard Investments first reported a position in Orexigen Therapeutics, Inc. in Q4 2013 and held it in 4 quarters.
  • Standard Investments's Orexigen Therapeutics, Inc. position peaked at $1.34M in Q2 2015.
  • 132 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2015.

Based on Standard Investments's 13F filing for Q3 2015, filed 16 Nov 2015.